>latest-news

Target Recalls Up & Up Baby Wipes After FDA Confirms Burkholderia cepacia Contamination

FDA confirms Burkholderia cepacia in Target's Up & Up baby wipes; supplier Sapro Temizlik Urunleri at center of nationwide recall covering eight SKUs.

Breaking News

  • Jun 06, 2026

  • Simantini Singh Deo

Target Recalls Up & Up Baby Wipes After FDA Confirms Burkholderia cepacia Contamination

A supplier-origin contamination event has placed Target's Up & Up baby wipe line at the center of a Class-level recall, with FDA testing confirming the presence of Burkholderia cepacia complex and Burkholderia gladioli in product samples across both Fragrance Free and Fresh Cucumber Scented SKUs. For QA directors and manufacturing leads producing aqueous-based products, the failure pattern here, pathogen detection triggered by consumer complaints of discoloration, not intercepted at incoming or in-process control points, is the more consequential detail.

Target announced the voluntary recall on June 4, 2026, covering eight SKUs in counts ranging from 20 to 1,200 units. Affected Fragrance Free wipes carry manufacturing date codes from November 7, 2025 through May 5, 2026; Fresh Cucumber Scented wipes are bounded to a two-day production window of December 29–30, 2025. The manufacturer of record is Sapro Temizlik Urunleri, a supplier whose products were distributed nationally through Target stores and Target.com.

The clinical risk profile is not incidental. Burkholderia cepacia complex is an opportunistic pathogen with documented lethality in immunocompromised patients, neonates, and infants, precisely the primary user population for baby wipes. FDA notes that in healthy individuals with intact skin, exposure may produce localized infection; in vulnerable populations, systemic spread to sepsis or pneumonia is a documented outcome. Adverse event reports received by Target and Sapro include skin irritation, eye irritation, and infections; those reports remain under active investigation.

For facilities operating under 21 CFR Part 211 or producing cosmetics under analogous GMP frameworks, the recall surfaces a familiar control gap: water activity and aqueous substrate management in wipe and liquid-format products creates persistent Burkholderia risk when supplier qualification, incoming raw material bioburden testing, and in-process microbial monitoring are not operating in concert. The ICH Q10 pharmaceutical quality system model's emphasis on continual improvement and CAPA closure applies directly to the supplier oversight dimension visible here, contamination that reached finished product and retail distribution was not contained at the supplier audit or incoming inspection stage.

Consumers are directed to stop use immediately and return product to any Target location for a full refund; Target Guest Relations is reachable at 1-800-440-0680 daily, 7 a.m. to 10 p.m. CT. The recall is being conducted with FDA's knowledge.

The two-day manufacturing window for the Cucumber Scented SKUs, set against a multi-month window for the Fragrance Free line, will likely focus investigator attention on water system event correlation and batch-level environmental monitoring records at the Sapro facility.

Source: U.S. Food and Drug Administration, Recalls, Market Withdrawals & Safety Alerts, June 5, 2026.

Ad
Advertisement